Copy

Canadian Glycomics Network: February 2017
Is this email not displaying correctly?
View this email in your browser
LinkedIn
Twitter
Website
Email
GlycoNet immuno-oncology workshop and panel discussion

 


Join us in discussing the role of glycomics in immuno-oncology.
Date: Wednesday, May 10, 2017
Time: 1:00pm – 5:00pm (MST)
Venue: The Banff Park Lodge

Free registration is now open!
GlycoNet scientists study bacterial glycan synthesis and chain length control 

By Chardelle Prevatt

Polysaccharides, or polymers that consist of a chain of sugar residues, are commonly used by pathogenic bacteria to counter host defences. By coating the bacterial surface in a protective layer, polysaccharides play vital roles in mediating host-pathogen interactions. Polysaccharide production is an energy expensive process. Bacteria have evolved quality control mechanisms in order to cover their surfaces with polymers whose chain lengths fall within a size range that is appropriate for function. This may limit energy “wasted” in producing polysaccharide chains that are longer than necessary.

In a paper, published in the Proceedings of the National Academy of Sciences, GlycoNet researchers—Drs. Chris Whitfield, Todd Lowary, Matthew Kimber, Iain Mainprize, Olga Ovchinnikova—and their colleagues Danielle Williams and Dr. Akihiko Koizumi outline one of the fundamental processes by which bacteria determine the composition and chain length of polysaccharides. Read more.

U of M based GlycoNet investigators identify novel anti-cancer agents

By Chardelle Prevatt

Cancer is the leading cause of death in Canada. According to the Canadian Cancer Society, an estimated 202,400 new cancer cases occurred in Canada in 2016, resulting in over 78,800 deaths. GlycoNet scientists, Drs. Frank Schweizer and Gilbert Arthur, together with a team of University of Manitoba (U of M) researchers, have identified a unique way to potentially treat and cure cancer, using carbohydrate-based antitumor agents.

Increasingly, studies support the idea that cancer stem cells (CSCs) are linked to tumor metastasis and resistance to chemotherapies. Therefore, eliminating CSCs is crucial to successful cancer treatment. In a paper published in the Journal of Medicinal Chemistry, Drs. Schweizer and Arthur, and their U of M collaborators, describe the synthesis of L-sugar analogues of an emerging class of glycolipids called glycosylated antitumor ether lipids (GAELs). Read more.

Now available: The 2017 Canadian Glycomics AGM, immuno-oncology workshop & symposium schedules

Join us at our upcoming May events in beautiful Banff, Alberta. 

For full schedule details, please click here.  Don't miss out! Register now.
GlycoNet Members in the News

Congratulations to all those recently published or making headlines!

Selected publications:

GlycoNet Departmental Seminar Series
Deadline: March 1, 2017 
The GlycoNet Departmental Seminar Series will assist in the dissemination of Network knowledge to the broader scientific community, as well as raise the profile and visibility of GlycoNet researchers and provide excellent opportunities for networking and collaborative discussions. 

For available funding and application guidelines, click here

Free Webinar: Integrating the Patient Voice in Health Research: The What, Why and How
Date: March 8, 2017 
Time: 1:00pm - 2:00pm (EST)
Presented by: Colleen McGavin, Patient Engagement Lead, BC SPOR SUPPORT Unit
This webinar will discuss what patient engagement is (and isn’t), why it’s important, and how BC’s Strategy for Patient-Oriented Research (SPOR) SUPPORT Unit is working to “get it right.” Learn more.

SMRTS Webcast: Media Relations - How to get your story in the press
Date: March 23, 2017 
Time: 1:00pm - 2:00pm (EST)
Presented by: Lisa Willemse, Senior Communications Advisor at the OIRM
LIVE: Room CCW5225, Sprott Centre at The Ottawa Hospital,  501 Smyth Road, Ottawa, ON
WEBCAST: goo.gl/6uvzFu
This webcast will look at what kinds of stories tend to get picked up by the media, how journalists work, and how you can better position your research for the mainstream media. Learn more.
 

We want to hear from you! 
Communicating your research findings is an important responsibility as a scientist. GlycoNet is here to support and promote communication of your research, but we need your help. Send photos, successes, milestones and information about awards and press coverage that you've received to glyconet@ualberta.ca.
Forward this newsletter!
Copyright © 2017 Canadian Glycomics Network, All rights reserved.